Latest Announcements

Redington Limited has announced its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, with revenue from operations at ₹25,224.83 crore and ₹42,946.91 crore respectively.

GPT Infraprojects Limited has announced the outcome of its Board Meeting held on November 4, 2026. The Board has approved the Un-Audited Financial Results for the 2nd quarter and half year ended September 30, 2026, declared a 1% Interim Dividend, and approved the incorporation of a limited Liability Partnership (LLP) named Ever Strong Highway LLP.

Jtekt India Limited has submitted its fifth monitoring agency report for the quarter ended September 30, 2026, regarding the utilization of funds raised through its rights issue of equity shares aggregating to Rs 249.89 Crore.

Ndr Auto Components Limited has informed the Exchange about Investor Presentation on the Financial Results for the quarter and six months ended 30th September 2026.

Marksans Pharma Limited has reported its unaudited financial results for the quarter and half year ended September 30, 2026, with revenue reaching ₹940 crore, up 30.5% YoY, and EBITDA growing 48.3% to a record ₹214 crore.

Dhoot Transmission Limited has informed the Exchange about Investor Presentation for Q2 FY 2026-27 financial results, with a revised presentation due to a typographical error.

Rajshree Polypack Limited has announced its Q2 and H1 FY2027 financial results, with revenue from operations at ₹102.90 Crores and ₹205.81 Crores respectively, and operating EBITDA at ₹13.05 Crores and ₹27.47 Crores respectively. The company has maintained its operating margins despite a sharp rise in raw material prices and softer export demand. The results also highlight the resilience of the business, with a strong domestic revenue growth of 37.37% YoY in Q2 and a growth of 21.82% YoY in H1.

Dr. Lal Path Labs Ltd. has informed the Exchange about General Updates, including the outcome of the Board Meeting held on November 04, 2026. The Board considered, noted and approved the un-audited financial results for the quarter and half year ended September 30, 2026, declaration of 2nd Interim Dividend of INR 5/- per equity share, appointment of Ms. Vasuta Agarwal as an Additional Director, and further investment in Subsidiary Company Dr. Lal PathLabs FZCO.

Meghmani Organics Limited has submitted its unaudited financial results for the second quarter and half year ended September 30, 2026, with a standalone profit of ₹5,812.84 and a comprehensive income of ₹4,555.76.

SMS Pharmaceuticals Limited has informed the Exchange about General Updates, including the outcome of the Board Meeting, financial results, and disclosure under Regulation 30 read with Schedule III of the SEBI (LODR) Regulations, 2015. The company has approved the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th September, 2026. The Board has also considered and approved the resignation of the Company Secretary & Compliance Officer, Mr. Thirumalesh Tumma, and appointed a new Company Secretary & Compliance Officer, Mr. Manohar Mollama.

CSB Bank Limited has informed the Exchange about the submission of a newspaper publication regarding the notice of postal ballot and remote e-voting for seeking approval of members on certain items of business.

Glass Wall Systems (India) Limited has published its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, in The Free Press Journal and Navshakti newspapers.

Marksans Pharma Limited has informed the Exchange about Investor Presentation for Q2FY27, with revenue reaching ₹940 crore, up 30.5% YoY, and EBITDA growing 48.3% to a record ₹214 crore.

Goyal Aluminiums Limited has informed the Exchange about the submission of newspaper advertisement pertaining to Un-Audited Financial Results for the quarter and half year ended 30th September, 2026.

Rolex Rings Limited has submitted its unaudited financial results for the quarter and half year ended September 30, 2026, which were approved by the Board of Directors and reviewed by the Audit Committee.

Dr. Lal Path Labs Ltd. has informed the Exchange regarding Outcome of Board Meeting held on November 04, 2026, where the Board of Directors considered, noted and approved the un-audited financial results for the quarter and half year ended September 30, 2026, declared 2nd interim dividend of INR 5/- per equity share, appointed Ms. Vasuta Agarwal as an Additional Director, and approved further investment in Dr. Lal PathLabs FZCO, a Wholly Owned Subsidiary of the Company.

Marksans Pharma Limited has submitted unaudited financial results for the quarter and half year ended September 30, 2026, approved by the Board of Directors. The results have been reviewed by the independent auditor M/s. MSKA & Associates LLP, with an unmodified opinion.

Jtekt India Limited has informed the Exchange about General Updates, including unaudited financial results for the second quarter ended 30th September, 2026, and the outcome of the meeting. The company also announced plans to invest Rs. 2,40,00,000 in a Special Purpose Vehicle for setting up a Group Captive Solar Power Project.

Jtekt India Limited has informed the Exchange regarding Outcome of Board Meeting held on November 04, 2026, where the Board approved unaudited financial results for the second quarter ended 30th September, 2026, and investment in a Special Purpose Vehicle for a Group Captive Solar Power Project.

SEDEMAC Mechatronics Limited has published unaudited financial results for the quarter and half year ended September 30, 2026, and has also announced a postal ballot notice for the approval of a special resolution to issue equity shares of the company through a postal ballot process.